Allt inom

The US Patent Office has approved Nanexa’s expanded patent application for the drug delivery platform PharmaShell®.

Uppsala 19th November 2019

 

The US Patent Office has approved Nanexa’s expanded patent application for the drug delivery platform PharmaShell®.

 

The US Patent Office has today approved another patent application for Nanexa.

Read more

Nanexa signs agreement with US pharmaceutical company for evaluation of PharmaShell®

Uppsala 19th November 2019

 

Nanexa signs agreement with US pharmaceutical company for evaluation of PharmaShell®

 

Nanexa has today signed a Material Transfer and Feasibility study Agreement with an unnamed global pharmaceutical company located in the US and a subsidiary of a global Japanese pharmaceutical company.

Read more